Atlas
Market PulseSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › BLUEJET

BLUEJET

Blue Jet Healthcare Limited
Small-capPharma ↗

What the six lenses say about BLUEJET — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹574.5
2026-07-10
VWAP · 1Y anchor
₹561
+2.5% from VWAP
P/E · TTM
—
no TTM EPS
52-week range
36%
position low→high
RSI(14)
67
momentum

Own sector index

Pharma ↗
Overweight

1M

+6.2%

3M

+15.8%

1Y

+16.2%

Breadth >EMA21

72%

How BLUEJET’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
4.0
avg conviction decile
Leadership
0/2
active lenses · Tech & Flow
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Small-cap cohortDRaw
TechnicalD665›

The actual numbers

Price vs VWAP (1y)+2.5%
EMA trend stackMixed
Price vs 200-EMA+12.1%
Price vs 50-EMA+15.7%
RSI(14)67
RS vs Nifty 500 · 3M+37.9%
RS vs sector · 3M+25.5%
52-week range36%
Volume vs 30d avg4.71×
Volume vs 60d avg5.73×
ATR(14) · volatility27.4
Bollinger width · vol contraction0.186
FundamentalD1083›

The actual numbers

Return on equity (ROE)52.1%
Return on capital (ROCE)57.3%
Operating margin35.8%
Net margin26.9%
Debt / equity0.00×

Full 8-quarter history in the financials table below.

ValuationD526›

The actual numbers

52-week range36%
CatalystD126›

The actual numbers

Earnings & momentum24
Capital actions11
Governance61

Every filing in the corporate-announcements panel below.

FlowD235›

The actual numbers

Promoter holding79.8%
Delivery · 30d avg41.0%
Up/down-day asymmetry-10.3pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D6 + D2 ) ÷ 2 = 4.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · High
62
Conviction score 62/100 · avg-decile strength 4.0/10
Conviction score62/100›
TechnicalD6›
FundamentalD10›
ValuationD5›
CatalystD1›
FlowD2›

Policy

Government policy · Pharma

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+1.8pp
+2.0pp
+19.1pp
+41.6pp
+21.6pp
-31.9pp
Nifty 500
Broad-market baseline
+1.3pp
+1.9pp
+18.5pp
+37.9pp
+16.5pp
-35.7pp
Sector
Own-sector index
—
—
+16.1pp
+25.5pp
+2.1pp
-53.6pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

BLUEJET daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
574.50+11.80

Relative strength

RS vs baseline · rebased to 100

BLUEJET ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
134.29+1.76

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

No quarterly financials available.

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 15 Jun '26
    LOWgovernance
    Spurt in Volume
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 Jun '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 11 Jun '26
    LOWgovernance
    Spurt in Volume
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 9 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 29 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 25 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 25 May '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 25 May '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 25 May '26
    MEDIUMcapital
    Dividend
    ›

    A dividend declaration — a cash return to shareholders.

    View original filing on NSE ↗
  • 25 May '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 19 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 2 Apr '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 Mar '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 28 Feb '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 19 Feb '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds BLUEJET

Mutual funds holding BLUEJET (1)

FundWeightAUM ₹crGrade
ICICI Pru Pharma Healthcare Diag Gr1.40%6,454

ETFs holding BLUEJET (0)

No tracked ETF holds BLUEJET ≥0.5%.

Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Pharma